These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 1662547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G, Stewart AG.
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F, Steiner E, Jouquey S, Godfroid JJ.
    J Lipid Mediat; 1989 Sep; 1(5):303-12. PubMed ID: 2562436
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 7. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A, Paul AK, Shukla SD.
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [Abstract] [Full Text] [Related]

  • 9. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG, Dusting GJ.
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [Abstract] [Full Text] [Related]

  • 10. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD, Moore JN.
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [Abstract] [Full Text] [Related]

  • 11. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD, Morrison WJ, Dhar A.
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [Abstract] [Full Text] [Related]

  • 12. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
    Stewart AG.
    Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H, Kudo I, Inoue K, Onozaki K, Tsushima S, Nomura H, Nojima S.
    J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
    [Abstract] [Full Text] [Related]

  • 15. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 16. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 18. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
    Hwang SB.
    J Lipid Mediat; 1990 Aug; 2(3-4):123-58. PubMed ID: 1966805
    [Abstract] [Full Text] [Related]

  • 19. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
    Curtin ML, Davidsen SK, Heyman HR, Garland RB, Sheppard GS, Florjancic AS, Xu L, Carrera GM, Steinman DH, Trautmann JA, Albert DH, Magoc TJ, Tapang P, Rhein DA, Conway RG, Luo G, Denissen JF, Marsh KC, Morgan DW, Summers JB.
    J Med Chem; 1998 Jan 01; 41(1):74-95. PubMed ID: 9438024
    [Abstract] [Full Text] [Related]

  • 20. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun 01; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.